Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUADUAL: Quadruple Half-Dose vs Dual Standard-Dose for Hypertension
NCT05377203Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jul 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of irbesartan, metoprolol, amlodipine, indapamide in hypertension (HTN), sponsored by Third Xiangya Hospital, Central South University. Started Jul 2022; status: completed.
02
Drugs
irbesartanmetoprololamlodipineindapamide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05377203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05377203.